Callisto Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011

Global Markets Direct, December 2011, Pages: 88

Callisto Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Callisto Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011” provides data on the Callisto Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Callisto Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Callisto Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Callisto Pharmaceuticals, Inc. - Brief Callisto Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Callisto Pharmaceutical

List of Tables
List of Figures
Callisto Pharmaceuticals, Inc. Snapshot
Callisto Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Callisto Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
Callisto Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Callisto Pharmaceuticals, Inc. – Pipeline Products Glance
Callisto Pharmaceuticals, Inc. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Callisto Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Callisto Pharmaceuticals, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Callisto Pharmaceuticals, Inc. – Drug Profiles
GT08
L-Annamycin
SP-304
SP-333
Callisto Pharmaceuticals, Inc. – Pipeline Analys

Customers who bought this item also bought

• Idenix Pharmaceuticals, Inc.
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Abbott Laboratories - IT Sales Opportunities - 2009
• Alibaba.com Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
• Kuehne and Nagel - IT Sales Opportunities - 2009
• Analysis of Yahoo! Inc
• Devoteam SA: Strategic Corporate Assessment - Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile
• Analysis of Google Inc
• SAVVIS, Inc.
• Analysis of Applied Materials, Inc.